Regulation
FDA clears Deep Reasoning AI’s NeuroDR for neurovascular CT scans
The FDA has granted 510(k) clearance to Deep Reasoning AI for NeuroDR, an AI software tool designed to assist in the analysis of neurovascular CT angiography scans. The clearance enables the vendor to market the diagnostic aid to hospitals and imaging centers for clinical use.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network